Related Experiment Videos
The NMDA macromolecular complex as a target for the development of anti-ischemic drugs
B Scatton1, J Benavides, C Carter
1Synthélabo Recherche, Biology Department, Bagneux, France.
Clinical Neuropharmacology
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Peripheral type benzodiazepine binding sites as a tool for the detection and quantification of CNS injury.
Current protocols in neuroscience·2008
New perspectives for the treatment of disorders of sleep and arousal.
Annales pharmaceutiques francaises·2007
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
The Journal of pharmacology and experimental therapeutics·2004
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.
The Journal of pharmacology and experimental therapeutics·2003
Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.
Clinical neuropharmacology·2026
Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.
Clinical neuropharmacology·2026
A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.
Clinical neuropharmacology·2026
Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.
Clinical neuropharmacology·2026
Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.
Clinical neuropharmacology·2026